Skip NavigationSkip to Content

HIVGenoPipe: a nextflow pipeline for the detection of HIV-1 drug resistance using a real-time sample-specific reference sequence

  1. Author:
    Dotrang,Thoai
    Sherman,Brad
    Dai,Lisheng
    Khan,Muhammad
    Highbarger,Helene
    Bruchey,Whitney
    Laverdure,Sylvain
    Baseler,Michael
    Imamichi,Tomozumi
    Dewar,Robin
    Chang,Weizhong
  2. Author Address

    Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA., Virus Isolation and Serology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA., Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA., Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA. Weizhong.chang@nih.gov.,
    1. Year: 2025
    2. Date: Jul 07
    3. Epub Date: 2025 07 07
  1. Journal: BMC Bioinformatics
    1. 26
    2. 1
    3. Pages: 168
  2. Type of Article: Article
  3. Article Number: 168
  1. Abstract:

    The emergence of HIV drug resistance is a challenge in controlling the acquired immunodeficiency syndrome (AIDS) pandemic caused by human immunodeficiency virus-1 (HIV-1) infection. Detection of drug resistance variants at minor frequencies can help to formulate successful antiretroviral therapy (ART) regimens for people living with HIV (PLWH) and reduce the emergence of drug resistance. Therefore, a pipeline which can accurately produce consensus nucleotide sequences and identify drug resistance mutations (DRMs) at defined frequency thresholds will be helpful in the treatment of PLWH, analysis of virus evolution, and the control of the pandemic. We have developed a pipeline, HIVGenoPipe, to determine HIV drug resistance variants within the gag-pol region above user-defined frequencies for HIV-1 samples sequenced using Illumina technology. The pipeline has been validated by comparing its results with the results generated by a widely used pipeline, HyDRA, which is limited to the pol region, and with the results generated by Sanger sequencing technology using the same set of 30 samples. The variant frequency used to generate ambiguous consensus sequences in HIVGenoPipe is more accurate than other pipelines because a sample-specific reference, which is generated in real-time with a novel hybrid strategy of de novo and reference-based assembly, is used for the frequency calculation, leading to more accurate drug resistance calls for use by clinicians. In addition, since Nextflow is used as the pipeline platform, HIVGenoPipe inherently has great portability, scalability and reproducibility; and the components can be updated or replaced independently if required. We developed HIVGenoPipe for the detection of HIV-1 drug resistance. It constructs more accurate gag-pol consensus sequences, leading to improved detection of DRMs. HIVGenoPipe is open source and freely available under the MIT license at https://github.com/LHRI-Bioinformatics/HIVGenoPipe . The current release (v1.0.1) is archived and available at https://doi.org/ https://doi.org/10.5281/zenodo.15528502 . © 2025. The Author(s).

    See More

External Sources

  1. DOI: 10.1186/s12859-025-06201-5
  2. PMID: 40624474
  3. PMCID: PMC12235847
  4. PII : 10.1186/s12859-025-06201-5

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel